Adaptimmune is a multinational, clinical-stage #biotech company focused on developing novel immunotherapies that can potentially transform cancer treatment

Dennis Williams
Senior Vice President, Late Stage Development
Elliot Norry
Senior Vice President and Chief Medical Officer
Gavin Wood
Chief Financial Officer
Helen Tayton-Martin
Chief Business Officer
Jo Brewer
Senior Vice President, Allogeneic Research
John Lunger
Chief Patient Supply Officer
Karen Miller
Senior Vice President, Pipeline Research
Mark Dudley
Senior Vice President, Early Stage Development
William Bertrand
Chief Operating Officer

No teams yet!

No jobs yet!

No wires yet!

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.